Long-term survival and complete response to adriamycin and etoposide in a case of hepatocellular carcinoma. uri icon

Overview

abstract

  • Hepatocellular carcinoma has a poor prognosis and is poorly responsive to systemic chemotherapy. Here we describe a case with unresectable hepatocellular carcinoma who achieved a complete response and has survived for more than 2 years, following treatment with a combination of adriamycin and etoposide (VP 16-213).

publication date

  • August 31, 1986

Research

keywords

  • Antineoplastic Combined Chemotherapy Protocols
  • Carcinoma, Hepatocellular
  • Liver Neoplasms

Identity

Scopus Document Identifier

  • 0022967529

PubMed ID

  • 3020753

Additional Document Info

volume

  • 72

issue

  • 4